Crossmark

Use of anakinra in the treatment of SARS-CoV-2 severe respiratory infection

Crossref DOI link: https://doi.org/10.1016/j.reumae.2022.02.001

Published Print: 2023-02

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Figuero-Pérez, Luis

Olivares-Hernández, Alejandro

Escala-Cornejo, Roberto A.

Cruz-Hernández, Juan J.
License Information

Text and Data Mining valid from 2023-02-01
More Information

This article is maintained by: Elsevier

Article Title: Use of anakinra in the treatment of SARS-CoV-2 severe respiratory infection

Journal Title: Reumatología Clínica (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.reumae.2022.02.001

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.reuma.2022.02.003

Content Type: simple-article

Copyright: © 2022 Elsevier España, S.L.U. and Sociedad Española de Reumatología y Colegio Mexicano de Reumatología. All rights reserved.